Internal Medicine, Infectious Disease · Bakersfield, CA
NPI
1710091749
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2222 19th Street
Bakersfield, CA, 93301
Phone (661) 325-2448
Groups this clinician bills Medicare through
Medicare paid, 2024
$127K
1,467 services
Medicare patients, 2024
420
Average age 71
Drug cost, 2024
$399K
933 prescriptions
Company payments, 2025
$676
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by See-Ruern S Kitt was code 99232 (hospital e&m - subsequent), 550 times for 204 patients. In total See-Ruern S Kitt billed 1,467 services in 5 codes, and Medicare paid $127K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 550 | 204 | $56.57 | $31K |
| 99214 Office E&M - Established | Office | 493 | 169 | $92.02 | $45K |
| 99223 Hospital E&M - Initial | Facility | 401 | 345 | $123.59 | $50K |
By year: 2022 $144K for 1,177 services; 2023 $126K for 1,207 services; 2024 $127K for 1,467 services.
Medicare prescription drug claims, 2024
In 2024, the drug See-Ruern S Kitt prescribed most often to Medicare patients was Fluconazole, with 81 prescriptions and refills. In total See-Ruern S Kitt wrote 933 Medicare prescriptions that cost $399K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluconazole Generic | 81 | 107 | 26 | $9,460 |
| Meropenem Generic | 67 | 67 | 15 | $18K |
| Doxycycline Hyclate Generic | 66 | 67 | 28 | $1,503 |
| Daptomycin Generic | 59 | 59 | Under 11 | $23K |
| Levofloxacin Generic | 54 | 56 | 30 | $1,004 |
| Cefdinir Generic | 45 | 45 | 21 | $1,257 |
| Sodium Chloride 0.9 % Sodium Chloride | 34 | 34 | 13 | $1,905 |
| Methenamine Hippurate Generic | 34 | 38 | 13 | $1,091 |
| Cefazolin Sodium Generic | 32 | 32 | Under 11 | $2,317 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 14 | $349 |
| Avycaz Ceftazidime/Avibactam | 26 | 26 | Under 11 | $177K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 26 | 26 | Under 11 | $3,833 |
| Cephalexin Generic | 25 | 27 | 11 | $685 |
| Vancomycin Hcl Generic | 22 | 22 | Under 11 | $4,861 |
| Ertapenem Ertapenem Sodium | 22 | 22 | Under 11 | $14K |
Brand drugs: 116 claims; generic drugs: 817 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid See-Ruern S Kitt $676 ($676 in general payments such as food, travel and fees) from 7 companies. The largest payer was Astellas Pharma US Inc with $298.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.